FK 3311

CAS No. 116686-15-8

FK 3311 ( FK-3311;COX-2 Inhibitor V )

Catalog No. M20632 CAS No. 116686-15-8

FK 3311 is a cell permeable and orally available sulfonanilide that acts as a COX-2 inhibitor and non-steroidal anti-inflammatory drug (NSAID).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 34 In Stock
5MG 55 In Stock
10MG 87 In Stock
25MG 151 In Stock
50MG 237 In Stock
100MG 354 In Stock
200MG 518 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    FK 3311
  • Note
    Research use only not for human use.
  • Brief Description
    FK 3311 is a cell permeable and orally available sulfonanilide that acts as a COX-2 inhibitor and non-steroidal anti-inflammatory drug (NSAID).
  • Description
    FK 3311 is a cell permeable and orally available sulfonanilide that acts as a COX-2 inhibitor and non-steroidal anti-inflammatory drug (NSAID).
  • Synonyms
    FK-3311;COX-2 Inhibitor V
  • Pathway
    Chromatin/Epigenetic
  • Target
    COX
  • Recptor
    COX-2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    116686-15-8
  • Formula Weight
    341.33
  • Molecular Formula
    C15H13F2NO4S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:100 mg/mL (292.97 mM)
  • SMILES
    CC(=O)c1ccc(NS(C)(=O)=O)c(Oc2ccc(F)cc2F)c1
  • Chemical Name
    N-(4-acetyl-2-(24-difluorophenoxy)phenyl)methanesulfonamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Oshima K Yabata Y Yoshinari D et al. The Effects of Cyclooxygenase (COX)-2 Inhibition on Ischemia-Reperfusion Injury in Liver Transplantation[J]. Journal of Investigative Surgery 2009 22(4):239-245.
molnova catalog
related products
  • Hederagenin

    Hederagenin is a triterpenoid saponin inhibiting LPS-stimulated expression of iNOS, COX-2, and NF-κB.

  • Acetylsalicylic acid

    Aspirin (Acetylsalicylic acid) is a potent and selective inhibitor of cyclooxygenase (COX) with a broad range of pharmacological activities including anti-inflammation and pain relief.

  • Roflumilast N-oxide

    Roflumilast N-oxide is a PDE type 4 inhibitor.